Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions

Thorax

Volumn 54, Issue 8, 1999, Pages 707-710

  Thickett, D R ^a   Armstrong, L ^a   Millar, A B ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Pathogenesis; Pleural effusions; Vascular endothelial growth factor

Indexed keywords

TYROSINE KINASE RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MESOTHELIUM CELL; PATHOGENESIS; PLEURA EFFUSION; PLEURA EMPYEMA; PRIORITY JOURNAL;

EID: 0032780749     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.54.8.707     Document Type: Article

References (22)

1. 1 Marel M, Zrustova M, Stasny B et al. The incidence of pleural effusion in a well-defined region. Epidemiologic study in central Bohemia. Chest 1993;104:1486-9.
2. 2 Light RW, Hamm H. Malignant pleural effusion: would the real cause please stand up? Eur Respir J 1997;10:1701-2.
3. 3 Breier G, Albrecht U, Sterrer S, et al. Expression of vascular endothelial growth factor during angiogenesis and endothelial cell differentiation. Development 1992;114:521-32.
4. 4 Berse B, Brown LF, Van de Water L, et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumours. Mol Biol Cell 1992;3:211-20.
5. 5 Potgens AJ, van Altena MC, Lubsen NH, et al. Analysis of the tumour vasculature and metastatic behaviour of xenografts of human melanoma cell lines transfected with vascular permeability factor. Am J Pathol 148:1203-17.
6. 6 Yeo KT, Wang HH, Nagy JA, et al. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumour and inflammatory effusions. Cancer Res 1993;53:2912-8.
7. 7 Tolnay E, Wiethege JE, Konig C, et al. Expression of vascular endothelial growth factor (VEGF) in malignant mesothelioma. Eur Respir J 1997;10(Suppl 25):395s.
8. 8 Volm M, Koomagi R, Mattern J. Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small cell carcinoma. Anticancer Res 1996;16:213-7.
9. 9 Takanami I, Tanaka F, Hashizume T, et al. Vascular endothelial growth factor and its receptors correlate with angiogenesis and survival in pulmonary adenocarcinoma. Anticancer Res 1997;17(4A):2811-4.
10. 10 Volm M, Koomagi R, Mattern J. Prognostic value of vascular endothelial growth factor and its receptor FLT-1 in squamous cell lung cancer. Int J Cancer 1997;74:64-8.
11. 11 Taichmann NS, Young S, Cruchley A, et al. Human neutrophils secrete vascular endothelial growth factor. J Leukoc Biol 1997;62:397-400.
12. 12 Fava RA, Olsen NJ, Spencer-Green G, et al. VPF/VEGF: accumulation and expression in human synovial fluids and rheumatoid joint tissue. J Exp Med 1994;18:341-6.
13. 13 Ikubo A, Morisaki T, Katano M, et al. A possible role of TGF-beta in the formation of malignant effusions. Clin Immunol Immunopathol 1995;77:27-32.
14. 14 Worrall NK, Chang K, LeJeune WS, et al. TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms. Am J Physiol 1997;273:H2565-74.
15. 15 Nagy KA, Masse EM, Herzberg KT, et al. Pathogenesis of ascites tumour growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res 1995;55:360-8.
16. 16 Millard FJC, Pepper JR. Pleural disease. In: Brewis RAL, ed. Respiratory Medicine, 2nd edition. Philadelphia: WB Saunders, 1995: 1564.
17. 17 Charan NB, Baile EM, Pare PD. Bronchial vascular congestion and angiogenesis. Eur Respir J 1997;10:1173-80.
18. 18 Gaudry M, Bregerie O, Andrieu V, et al. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 1997;90:4153-61.
19. 19 Boussat S, Eddahibi S, Coste B, et al. Vascular endothelial growth factor (VEGF) expression in human pulmonary epithelial cells: upregulation by cytokines and hypoxia. Am J Respir Crit Care Med 1998;157:A354.
20. 20 Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-39.
21. 21 Nehls V, Herrmann R. The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration. Microvasc Res 1996;51:347-64.
22. 22 Brem S. Angiogenesis antagonists: current clinical trials. Angiogenesis 1998;2:9-20.